Acutaas Opens Its Korea Chemicals Plant and Adds ₹212 Cr Gujarat Capex; ECMS Incentive Covers Battery Additives
Indichem's Gongju plant opened Aug 28, eleven months after groundbreaking. The board cleared up to ₹212 Cr for a Gujarat plant; MeitY approved an ECMS incentive on ₹119 Cr.
₹3,281.60
Aug 28 close, −1.4% on the day
LARGE-CAP
₹1,000+ price band
₹1,570–3,740
−12.3% from high, +109% from low
₹329.7 Cr
Consolidated, +59.1% YoY, −23.8% QoQ
34.3%
24.6% a year ago; 42.4% in Q4 FY26
2.57L
5-day avg 2.57L
Three announcements in ten days
On August 28, Acutaas Chemicals announced that Indichem Inc., its step-down subsidiary in South Korea, had inaugurated a semiconductor materials plant at Gongju, Chungcheongnam-do, completed within eleven months of the September 29, 2025 groundbreaking. Acutaas Advance Material Limited, a wholly owned subsidiary, and J & Materials Co. Ltd hold the venture 75:25; AAML has invested KRW 30 billion (about ₹200 crore). The stated model: chemicals synthesised in India, refined and qualified to semiconductor grade in Korea, near customers. The release describes the plant as inaugurated and commissioned; it does not state a commercial-production date or capacity.
Indichem inaugurates semiconductor materials plant at Gongju, South Korea
Plant on 16,513.7 sq m across three buildings (production block, HQ/R&D/pilot plant, warehouse), with land for expansion. JV held 75:25 by AAML and J & Materials; AAML investment KRW 30 bn (~₹200 Cr).
Read:The release reached the exchange at 14:21 IST during trading. The stock closed 1.4% lower at ₹3,281.60 on 2.4 lakh shares, close to the 20-day average.
BSE filing, Aug 28, 2026Board approves capex of up to ₹212 Cr for an electronic-grade chemicals plant in Gujarat
Outcome of the Saturday, August 22 board meeting: a greenfield/brownfield plant for new electronic-grade chemicals in Gujarat, to be undertaken by the company or a subsidiary. The same meeting adopted the FY26 annual report and set the AGM for September 24.
Read:Filed on a Saturday evening. The next session, Monday August 24, closed 0.1% higher at ₹3,173.
BSE filing, Aug 22, 2026MeitY approves ECMS incentive package for the electrolyte additives business at Jhagadia
Approval letter dated August 17 via Engineers India Ltd as project management agency. Cumulative project investment ₹256.47 Cr, of which ₹119.12 Cr is eligible; incentive up to 25% of eligible investment (about ₹30 Cr) through FY2030-31, subject to scheme conditions.
Read:Filed at 16:19 IST, after the close. The stock had already risen 6.0% that day to ₹3,391.40 on 4.2 lakh shares; it fell 4.8% the next session. Electrolyte additives are battery chemicals, a separate line from the semiconductor materials made in Korea.
BSE filing, Aug 18, 2026Q1 FY27, consolidated
The Q1 FY27 press release (July 24) reports consolidated revenue of ₹329.7 crore, up 59.1% year on year but down 23.8% from Q4 FY26. EBITDA was ₹113.1 crore at a 34.3% margin, against 24.6% in Q1 FY26 and 42.4% in Q4 FY26. PAT was ₹75.0 crore (22.7% margin), up 70.4% year on year and down 44.2% from the March quarter. The company describes itself as a manufacturer of advanced pharmaceutical intermediates and specialty chemicals; the release does not name customers.
Read together: revenue and margins are well above a year ago and below the two quarters before this one. The release gives FY27 revenue growth guidance of 25%. Whether the Korea plant, the ₹212 crore Gujarat plant and the ECMS-backed additives line change the margin profile is not something the filings yet quantify: none of the three gives a revenue or capacity figure.
Price since May
50
Neutral
3281.6
−12.3% from high
- vs 20-DMA (₹3,238)
- vs 50-DMA (₹3,362)
- vs 200-DMA (₹2,488)
Between 20- and 50-day averages
₹3,700
30-day high
₹3,281.60
₹3,025
30-day low
The disclosures that would add numbers to the story
korea-production
A filing or call commentary giving Indichem's commercial-production start, capacity or first customer qualifications.
gujarat-capex
Details of the ₹212 Cr plant: location, products, timeline, funding, and whether it sits in the company or a subsidiary.
q2-results
Q2 FY27 results (Oct–Nov): revenue against the 25% FY27 growth guidance and where the EBITDA margin settles after 42.4% → 34.3%.
ecms-milestones
ECMS disbursement milestones on the ₹119.12 Cr eligible investment through FY2030-31.
Three filings in ten days describe capacity being added: a Korean refining plant now open, a Gujarat plant approved, and a government incentive on the battery-additives line. None yet carries a revenue number.
The last reported quarter shows strong year-on-year growth and a margin that has come off its Q4 peak. The next results and any production update from Gongju are what would turn the capacity story into an earnings one.
Informational and educational content only. Not investment advice.